These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8097861)

  • 21. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DAMGO, a mu-opioid receptor selective ligand, distinguishes between mu-and kappa-opioid receptors at a different region from that for the distinction between mu- and delta-opioid receptors.
    Minami M; Onogi T; Nakagawa T; Katao Y; Aoki Y; Katsumata S; Satoh M
    FEBS Lett; 1995 May; 364(1):23-7. PubMed ID: 7750536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of postmortem delay on mu, delta and kappa opioid receptor subtypes in rat brain and guinea pig cerebellum evaluated by radioligand receptor binding.
    Paul D; Gauthier CA; Minor LD; Gonzales GR
    Life Sci; 1997; 61(20):1993-8. PubMed ID: 9366506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
    Raynor K; Kong H; Chen Y; Yasuda K; Yu L; Bell GI; Reisine T
    Mol Pharmacol; 1994 Feb; 45(2):330-4. PubMed ID: 8114680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An investigation of the N-demethylation of 3-deoxymorphine and the affinity of the alkylation products to mu, delta, and kappa receptors.
    Csutoras C; Zhang A; Bidlack JM; Neumeyer JL
    Bioorg Med Chem; 2004 May; 12(10):2687-90. PubMed ID: 15110850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells.
    Standifer KM; Cheng J; Brooks AI; Honrado CP; Su W; Visconti LM; Biedler JL; Pasternak GW
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1246-55. PubMed ID: 7932177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The region in the mu opioid receptor conferring selectivity for sufentanil over the delta receptor is different from that over the kappa receptor.
    Zhu J; Xue JC; Law PY; Claude PA; Luo LY; Yin J; Chen C; Liu-Chen LY
    FEBS Lett; 1996 Apr; 384(2):198-202. PubMed ID: 8612823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
    Zadina JE; Kastin AJ; Ge LJ; Hackler L
    Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors.
    Chen Y; Mestek A; Liu J; Yu L
    Biochem J; 1993 Nov; 295 ( Pt 3)(Pt 3):625-8. PubMed ID: 8240267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of μ-, δ- and κ-opioid receptors in forebrain cortex of rats exposed to morphine for 10 days: Comparison with animals after 20 days of morphine withdrawal.
    Ujcikova H; Hlouskova M; Cechova K; Stolarova K; Roubalova L; Svoboda P
    PLoS One; 2017; 12(10):e0186797. PubMed ID: 29053731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells.
    Hirota K; Okawa H; Appadu BL; Grandy DK; Devi LA; Lambert DG
    Anesthesiology; 1999 Jan; 90(1):174-82. PubMed ID: 9915326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the amino acid residues involved in selective agonist binding in the first extracellular loop of the delta- and mu-opioid receptors.
    Fukuda K; Terasako K; Kato S; Mori K
    FEBS Lett; 1995 Oct; 373(2):177-81. PubMed ID: 7589460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions of N-cyclopropylmethyl(-)-6 beta-acetylthionormorphine with mu-, kappa-, delta- and sigma-opioid receptors.
    Takayanagi I; Koike K; Satoh M
    Gen Pharmacol; 1991; 22(5):965-7. PubMed ID: 1662176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
    Gengo PJ; Pettit HO; O'Neill SJ; Wei K; McNutt R; Bishop MJ; Chang KJ
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1221-6. PubMed ID: 14534368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic Evidence for a Putative Conserved Allosteric Site on Opioid Receptors.
    Livingston KE; Stanczyk MA; Burford NT; Alt A; Canals M; Traynor JR
    Mol Pharmacol; 2018 Feb; 93(2):157-167. PubMed ID: 29233847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives.
    Franchini S; Battisti UM; Prandi A; Tait A; Borsari C; Cichero E; Fossa P; Cilia A; Prezzavento O; Ronsisvalle S; Aricò G; Parenti C; Brasili L
    Eur J Med Chem; 2016 Apr; 112():1-19. PubMed ID: 26874044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of sigma ligands on the cloned mu-, delta- and kappa-opioid receptors co-expressed with G-protein-activated K+ (GIRK) channel in Xenopus oocytes.
    Kobayashi T; Ikeda K; Ichikawa T; Togashi S; Kumanishi T
    Br J Pharmacol; 1996 Sep; 119(1):73-80. PubMed ID: 8872359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential binding properties of oripavines at cloned mu- and delta-opioid receptors.
    Lee KO; Akil H; Woods JH; Traynor JR
    Eur J Pharmacol; 1999 Aug; 378(3):323-30. PubMed ID: 10493109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.
    Matthes HW; Maldonado R; Simonin F; Valverde O; Slowe S; Kitchen I; Befort K; Dierich A; Le Meur M; Dollé P; Tzavara E; Hanoune J; Roques BP; Kieffer BL
    Nature; 1996 Oct; 383(6603):819-23. PubMed ID: 8893006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole 'nitazene' synthetic opioid.
    Vandeputte MM; Krotulski AJ; Walther D; Glatfelter GC; Papsun D; Walton SE; Logan BK; Baumann MH; Stove CP
    Arch Toxicol; 2022 Jun; 96(6):1845-1863. PubMed ID: 35477798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.